Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Is a |
Oxycodone product |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Is a |
oxycodonhydrochlorid |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Is a |
Product containing paracetamol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Non-opioid analgesic (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Oxycodone hydrochloride (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Paracetamol |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Is a |
paracetamol + oxycodonhydrochlorid |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Has manufactured dose form |
Oral solution |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Is a |
Product containing paracetamol in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
paracetamol 325 mg + oxycodonhydrochlorid 5 mg opløsning |
Is a |
Oxycodone-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|